Call for Abstract

Scientific Program

2nd International Conference on Respiratory and Pulmonary Medicine, will be organized around the theme “Neoteric developments in Respiratory Research and Treatment ”

Respiratory Medicine 2016 is comprised of 16 tracks and 87 sessions designed to offer comprehensive sessions that address current issues in Respiratory Medicine 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Track 1:Lung Disease: Alveoli

The alveoli are located in the respiratory zone of the lungs, at the distal termination of the alveolar ducts and atria. These air sacs are the forming and termination point of the respiratory tract. The alveoli consist of an epithelial layer and extracellular matrix surrounded by capillaries. In some alveolar walls there are pores between alveoli called Pores of Kohn. The alveoli contain some collagen and elastic fibres. The elastic fibres allow the alveoli to stretch as they are filled with air during inhalation. They then spring back during exhalation in order to expel the carbon dioxide-rich air.

Millions of people in the U.S. have lung disease. If all types of lung disease are lumped together, it is the number three killer in the United States.

 

  • Track 1-1Pneumonia
  • Track 1-2Tuberculosis
  • Track 1-3Pulmonary edema
  • Track 1-4Acute respiratory distress syndrome
  • Track 1-5Pneumoconiosis
  • Track 1-6Pulmonary sarcoidosis
  • Track 1-7Bronchoscopy

Track 2:Lung Infections

A chest infection is an infection that affects your lungs, either in the larger airways (bronchitis) or in the smaller air sacs (pneumonia). There is a build-up of pus and fluid (mucus), and the airways become swollen, making it difficult for you to breathe. Chest infections can affect people of all ages. Young children and the elderly are most at risk, as well as people who are ill and smokers. A chest infection can be serious for these people.

  • Track 2-1Bronchitis
  • Track 2-2Lung adenocarcinoma
  • Track 2-3Tonsilitis and Sinusitis
  • Track 2-4Chronic Cough and Flu
  • Track 2-5Influenza
  • Track 2-6Pathogenic infections
  • Track 2-7Fungal infections
  • Track 2-8ALS and Respiratory infections

Track 3:Tuberculosis

TB is an infectious disease that usually affects the lungs. It is the second greatest killer due to a single infectious agent worldwide, and in 2012, 1.3 million people died from the disease, with 8.6 million falling ill. The Mycobacterium tuberculosis bacterium causes TB. It is spread through the air from person to person, when people with TB affecting the lungs cough, sneeze, spit, laugh or talk. TB is contagious, but it is not easy to catch. 

 

 

  • Track 3-1Pathogenesis and Epidemiology of tuberculosis
  • Track 3-2Multi Drug Resistance to Tuberculosis
  • Track 3-3Current Research in Drugs and Vaccines for tuberculosis
  • Track 3-4New treatment Strategies for tuberculosis and HIV

Track 4:Pulmonary Fibrosis

Pulmonary fibrosis is a disease marked by scarring in the lungs. Tissue deep in the lungs becomes thick, stiff and scarred. The scarring is called fibrosis. As the lung tissue becomes scarred, it interferes with a person's ability to breathe. In some cases, the cause of pulmonary fibrosis can be found. But most cases of pulmonary fibrosis have no known cause. These cases are called idiopathic pulmonary fibrosis.

  • Track 4-1Idiopathic pulmonary fibrosis
  • Track 4-2Pathogenesis of pulmonary fibrosis
  • Track 4-3Pharmacologic interventions of pulmonary fibrosis
  • Track 4-4Advances in pulmonary fibrosis

Track 5:Lung Problems

Lung disease is any problem in the lungs that prevents the lungs from working properly. There are three main types of lung disease:

Airway diseases  affect the tubes (airways) that carry oxygen and other gases into and out of the lungs. They usually cause a narrowing or blockage of the airways. Airway diseases include asthma, emphysema, bronchiectasis, and chronic bronchitis. People with airway diseases often say they feel as if they are "trying to breathe out through a straw."

 

  • Track 5-1Lung organogenesis
  • Track 5-2Lung biology and diseases
  • Track 5-3Lung cancer: challenges and Methodologies
  • Track 5-4Lung carcinomas and asbestosis

Track 6:Emphysema

Emphysema is a form of chronic (long-term) lung disease. People with emphysema have difficulty breathing from a limitation in blowing air out. There are multiple causes of emphysema, but smoking is by far the most common.
 
  • Track 6-1Pathogenesis of emphysema
  • Track 6-2Risk factors for emphysema
  • Track 6-3Pulmonary rehabilitation for emphysema
  • Track 6-4Tests for emphysema
  • Track 6-5Advance treatment for emphysema

Track 7:Cystic fibrosis

Cystic Fibrosis is a life-threatening disorder that causes severe damage to the lungs and digestive system. An inherited condition, cystic fibrosis affects the cells that produce mucus, sweat and digestive juices. These secreted fluids are normally thin and slippery. But in cystic fibrosis, a defective gene causes the secretions to become thick and sticky. Instead of acting as a lubricant, the secretions plug up tubes, ducts and passageways, especially in the lungs and pancreas.

 

 

  • Track 7-1Pathophysiology of cystic fibrosis
  • Track 7-2Epidemology of cystic fibrosis
  • Track 7-3Perioperative Management of the Adult with cystic fibrosis
  • Track 7-4Advance treatment for cystic fibrosis

Track 8:COPD

COPD, or chronic obstructive pulmonary (PULL-mun-ary) disease, is a progressive disease that makes it hard to breathe. "Progressive" means the disease gets worse over time.
COPD can cause coughing that produces large amounts of mucus (a slimy substance), wheezing, shortness of breath, chest tightness, and other symptoms.
Cigarette smoking is the leading cause of COPD. Most people who have COPD smoke or used to smoke. Long-term exposure to other lung irritants—such as air pollution, chemical fumes, or dust—also may contribute to COPD.
  • Track 8-1Diagnostic treatments and Rehabilitation of COPD
  • Track 8-2Pathophysiology of COPD
  • Track 8-3COPD Pragnosis and Primary care
  • Track 8-4COPD Risk factors and Management
  • Track 8-5Diagnosis of COPD

Track 9:Allergic Diseases 

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to something in the environment that usually causes little problem in most people. These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, runny nose, shortness of breath, or swelling. Food intolerances and food poisoning are separate conditions.

 

  • Track 9-1Types of Allergic Diseases
  • Track 9-2Mangement of allergic diseases
  • Track 9-3Tests in the diagnosis of allergic diseases
  • Track 9-4Probiotic and prevention of allargic diseases

Track 10:Chronic Bronchitis 

Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus, as well as shortness of breath, wheezing, and chest tightness. There are two main types of bronchitis: acute and chronic.
 
  • Track 10-1Risk factors for Chronic Bronchitis
  • Track 10-2Prognosis for chronic bronchitis
  • Track 10-3Medical care for Chronic bronchitis
  • Track 10-4Prevention of Chronic Bronchitis

Track 11:Asthma 

To understand asthma, it helps to know how the airways work. The airways are tubes that carry air into and out of your lungs. People who have asthma have inflamed airways. The inflammation makes the airways swollen and very sensitive. The airways tend to react strongly to certain inhaled substances.
When the airways react, the muscles around them tighten. This narrows the airways, causing less air to flow into the lungs. The swelling also can worsen, making the airways even narrower. Cells in the airways might make more mucus than usual. Mucus is a sticky, thick liquid that can further narrow the airways.
This chain reaction can result in asthma symptoms. Symptoms can happen each time the airways are inflamed.
  • Track 11-1Asthma prevention and cure: Novel techniques
  • Track 11-2Pulmonogists and therapeutic care
  • Track 11-3Asthma therapy and Types of testing
  • Track 11-4Advanced Stages in Asthma allergens
  • Track 11-5Stages in asthma detetction
  • Track 11-6Clinical diagnostics & treatment methods
  • Track 11-7Asthma vaccine & drug development

Track 12:Lung Cancer

There are two major types of lung cancer, non-small cell lung cancer and small cell lung cancer staging lung cancer is based on whether the cancer is local or has spread from the lungs to the lymph nodes or other organs. Because the lungs are large, tumours can grow in them for a long time before they are found. Even when symptoms such as coughing and fatigue do occur, people think they are due to other causes. For this reason, early-stage lung cancer is difficult to detect. Most people with lung cancer are diagnosed at stages III and IV.
 
  • Track 12-1Lung cancer and metabolic diosorders
  • Track 12-2Smoking and risk factors
  • Track 12-3Pathogenesis
  • Track 12-4Types of Lung Cancer and testing
  • Track 12-5Small cell lung cancers and Non-small cell lung cancers
  • Track 12-6Lung carcinoma metastasis and Breast cancer
  • Track 12-7Screening and treatment strategies
  • Track 12-8Radiotherapy & Chemotherapy
  • Track 12-9Targeting drugs and Pharmaceutical business
  • Track 12-10Lung cancer and Palliative care
  • Track 12-11Advanced stages in Lung cancer and metabolic diosorders

Track 13:Pulmonary Function Test

Pulmonary function tests are a group of tests that measure how well the lungs take in and release air and how well they move gases such as oxygen from the atmosphere into the body's circulation.
Spirometry measures airflow. By measuring how much air you exhale, and how quickly, spirometry can evaluate a broad range of lung diseases. In a spirometry test, while you are sitting, you breathe into a mouthpiece that is connected to an instrument called a spirometer. The spirometer records the amount and the rate of air that you breathe in and out over a period of time.
  • Track 13-1Static and dynamic lung volumes-interpretation and performance
  • Track 13-2Body plethysmography- interpretation
  • Track 13-3Ventilation–perfusion measurement- interpretation
  • Track 13-4Exercise testing including walking tests and spiroergometry
  • Track 13-5Blood gas assessment and oximetry- interpretation and performance
  • Track 13-6Bronchial provocation testing- interpretation and performance

Track 14:Advances in Respiratory Medicine

Routine lung function and respiratory muscle testing are recommended in children with neuromuscular disease (NMD), but these tests are based on non-invasive volitional manoeuvres, such as the measurement of lung volumes and maximal static pressures, that young children may not always be able to perform. The realization of simple natural manoeuvres such as a sniff or a cough, and the measurement of oesophageal and gastric pressures during spontaneous breathing can add valuable information about the strength and endurance of the respiratory muscles in young children. 
 
  • Track 14-1Management of Idiopathic Pulmonary Fibrosis
  • Track 14-2Diagnosing and Staging Lung Cancer Involving the Mediastinum
  • Track 14-3Aspiration Related Pulmonary Syndromes
  • Track 14-4Respiratory Muscle Testing in Children with Neuromuscular Disease
  • Track 14-5Respiratory Syncytial Virus infection and Treatment

Track 15:Respiratory Pharmacology

Respiratory pharmacology primarily deals with agents used to treat the “pathological triad” of pulmonary disease. The pathological triad consists of: bronchospasm, airway inflammation, and retained secretions. Agents used to treat these conditions consist of bronchodilators, antimuscarinics, corticosteroids, mucokinetics, mucolytic, and decongestants, among others. Additional agents used in the treatment of pulmonary disease are oxygen, antibiotics, local anaesthetics’, respiratory stimulants, and muscle relaxers. All of these, with the exception of oxygen, are discussed in this paper. Particular emphasis is placed on medications delivered in an aerosol form.
  • Track 15-1Antiasthmatic Drugs
  • Track 15-2Bronchodilators
  • Track 15-3Decogestants
  • Track 15-4Expectorants

Track 16:Respiratory and Pulmonary Therapies

A respiratory therapist is a specialized healthcare practitioner who has graduated from a university and passed a national board certifying examination. Respiratory therapists work most often in intensive care and operating rooms, but are also commonly found in outpatient clinics and home-health environments.
Respiratory therapists are specialists and educators in cardiology and pulmonology. Respiratory therapists are also advanced-practice clinicians in airway management; establishing and maintaining the airway during management of trauma, intensive care, and may administer anaesthesia for surgery or conscious sedation.
 
  • Track 16-1Respiratory Agents
  • Track 16-2Occupational lung diseases and therapy
  • Track 16-3Respiratory acidosis treatment
  • Track 16-4Nutritional approaches to lung disease
  • Track 16-5Interventional Pulmonology